US Stock MarketDetailed Quotes

OKYO OKYO Pharma

Watchlist

1.160
-0.040-3.33%

Close Nov 4 16:00 ET

1.140
-0.020-1.72%

Post 16:00 ET

39.25MMarket Cap-2035P/E (TTM)

OKYO Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(FY)Mar 31, 2023

(FY)Mar 31, 2022

(FY)Mar 31, 2021

(FY)Mar 31, 2020

(FY)Mar 31, 2019

(FY)Mar 31, 2018

(FY)Mar 31, 2017

(FY)Mar 31, 2016

(FY)Mar 31, 2015

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-23.33%-9.49M

-40.73%-7.7M

-241.71%-5.47M

-33.12%-1.6M

39.59%-1.2M

-24.77%-1.99M

-144.89%-1.59M

-0.06%-651.27K

91.85%-650.88K

-131.16%-7.98M

Net income from continuing operations

-26.49%-16.8M

-113.65%-13.28M

-84.03%-6.22M

-108.50%-3.38M

66.95%-1.62M

82.66%-4.9M

-11,584.05%-28.27M

70.50%-241.93K

90.06%-820.17K

40.72%-8.26M

Operating gains losses

7.80%55.18K

644.07%51.19K

-390.58%-9.41K

-76.73%3.24K

1,292.03%13.92K

-100.00%-1.17K

--26.39M

----

-127.31%-26.9K

77.71%98.48K

Depreciation and amortization

1.82%3.87K

62.89%3.8K

-82.22%2.33K

119.28%13.11K

2,644.97%5.98K

--217.8166

--0

----

Other non cash items

2,912.53%3.46M

86.31%114.99K

-25.64%61.72K

93.73%83.01K

-98.40%42.85K

991.02%2.69M

--246.21K

----

28.53%-12.36K

-517.57%-17.29K

Change In working capital

-32.35%2.67M

485.38%3.95M

-197.99%-1.02M

460.14%1.04M

5.50%186.53K

395.04%176.81K

108.35%35.72K

-491.19%-427.71K

246.35%109.34K

-34.37%-74.71K

-Change in receivables

--0

-86.65%27.38K

267.09%205.07K

6.41%-122.73K

-165.98%-131.14K

155.03%198.76K

-584.16%-361.21K

1,536.60%74.61K

94.94%-5.19K

-Change in payables and accrued expense

-41.00%2.23M

1,616.75%3.78M

-129.66%-249.09K

171.54%839.78K

0.43%309.27K

288.88%307.95K

-145.16%-163.04K

-291.48%-66.51K

149.96%34.73K

-247.53%-69.52K

-Change in other current assets

162.50%440.26K

120.91%167.72K

---802.15K

----

Cash from discontinued investing activities

6.56M

Operating cash flow

-23.33%-9.49M

-40.73%-7.7M

-241.71%-5.47M

-33.12%-1.6M

39.59%-1.2M

-24.77%-1.99M

-144.89%-1.59M

-0.06%-651.27K

54.08%-650.88K

58.95%-1.42M

Investing cash flow

Cash flow from continuing investing activities

-254.46%-5.92K

90.79%-1.67K

86.35%-18.11K

-9,931.22%-132.67K

-1.32K

87.85%-335.18K

73.95%-2.76M

Capital expenditure reported

----

85.28%-405.59K

73.48%-2.75M

Net PPE purchase and sale

--0

-254.46%-5.92K

75.96%-1.67K

---6.94K

--0

---1.32K

--0

----

1,552.67%70.41K

97.67%-4.85K

Net other investing changes

----

91.58%-11.17K

---132.67K

----

Cash from discontinued investing activities

Investing cash flow

--0

-254.46%-5.92K

90.79%-1.67K

86.35%-18.11K

-9,931.22%-132.67K

---1.32K

--0

----

87.85%-335.18K

73.95%-2.76M

Financing cash flow

Cash flow from continuing financing activities

-33.41%6.21M

332.99%9.32M

-72.49%2.15M

712.50%7.83M

963.31K

-96.66%12.36K

-96.45%370.51K

Net issuance payments of debt

--0

--2M

--0

27,839.94%7.58M

---27.33K

--0

----

-28.53%12.36K

--17.29K

Net common stock issuance

-15.22%6.21M

--7.32M

--0

-76.78%230.02K

--990.64K

--0

----

Proceeds from stock option exercised by employees

--0

13,468.18%2.15M

--15.87K

--0

----

56.50%353.22K

Cash from discontinued financing activities

Financing cash flow

-33.41%6.21M

332.99%9.32M

-72.49%2.15M

712.50%7.83M

--963.31K

--0

----

-96.66%12.36K

-96.45%370.51K

Net cash flow

Beginning cash position

49.79%4.05M

-60.80%2.7M

2,825.59%6.89M

-62.48%235.49K

-76.03%627.62K

-40.60%2.62M

0.23%4.41M

-29.89%4.4M

-40.36%6.27M

-33.03%10.52M

Current changes in cash

-302.32%-3.28M

148.91%1.62M

-153.42%-3.32M

1,771.58%6.21M

81.35%-371.42K

-24.85%-1.99M

-144.89%-1.59M

33.11%-651.27K

74.42%-973.71K

-5.32%-3.81M

Effect of exchange rate changes

122.88%63.5K

68.18%-277.54K

-295.89%-872.14K

2,249.98%445.22K

---20.71K

----

--0

30.64%-171.84K

8.21%-247.75K

End cash Position

-79.56%826.85K

49.79%4.05M

-60.80%2.7M

2,825.59%6.89M

-62.48%235.49K

-77.70%627.56K

-24.91%2.81M

-26.93%3.75M

-20.67%5.13M

-45.32%6.47M

Free cash flow

-23.24%-9.49M

-40.80%-7.7M

-240.34%-5.47M

-33.70%-1.61M

39.63%-1.2M

-24.85%-1.99M

-144.89%-1.59M

38.38%-651.27K

74.70%-1.06M

70.38%-4.18M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Mar 31, 2024	(FY)Mar 31, 2023	(FY)Mar 31, 2022	(FY)Mar 31, 2021	(FY)Mar 31, 2020	(FY)Mar 31, 2019	(FY)Mar 31, 2018	(FY)Mar 31, 2017	(FY)Mar 31, 2016	(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-23.33%-9.49M	-40.73%-7.7M	-241.71%-5.47M	-33.12%-1.6M	39.59%-1.2M	-24.77%-1.99M	-144.89%-1.59M	-0.06%-651.27K	91.85%-650.88K	-131.16%-7.98M
Net income from continuing operations	-26.49%-16.8M	-113.65%-13.28M	-84.03%-6.22M	-108.50%-3.38M	66.95%-1.62M	82.66%-4.9M	-11,584.05%-28.27M	70.50%-241.93K	90.06%-820.17K	40.72%-8.26M
Operating gains losses	7.80%55.18K	644.07%51.19K	-390.58%-9.41K	-76.73%3.24K	1,292.03%13.92K	-100.00%-1.17K	--26.39M	----	-127.31%-26.9K	77.71%98.48K
Depreciation and amortization	1.82%3.87K	62.89%3.8K	-82.22%2.33K	119.28%13.11K	2,644.97%5.98K	--217.8166	--0	----	----	----
Other non cash items	2,912.53%3.46M	86.31%114.99K	-25.64%61.72K	93.73%83.01K	-98.40%42.85K	991.02%2.69M	--246.21K	----	28.53%-12.36K	-517.57%-17.29K
Change In working capital	-32.35%2.67M	485.38%3.95M	-197.99%-1.02M	460.14%1.04M	5.50%186.53K	395.04%176.81K	108.35%35.72K	-491.19%-427.71K	246.35%109.34K	-34.37%-74.71K
-Change in receivables	--0	--0	-86.65%27.38K	267.09%205.07K	6.41%-122.73K	-165.98%-131.14K	155.03%198.76K	-584.16%-361.21K	1,536.60%74.61K	94.94%-5.19K
-Change in payables and accrued expense	-41.00%2.23M	1,616.75%3.78M	-129.66%-249.09K	171.54%839.78K	0.43%309.27K	288.88%307.95K	-145.16%-163.04K	-291.48%-66.51K	149.96%34.73K	-247.53%-69.52K
-Change in other current assets	162.50%440.26K	120.91%167.72K	---802.15K	----	----	----	----	----	----	----
Cash from discontinued investing activities									0	6.56M
Operating cash flow	-23.33%-9.49M	-40.73%-7.7M	-241.71%-5.47M	-33.12%-1.6M	39.59%-1.2M	-24.77%-1.99M	-144.89%-1.59M	-0.06%-651.27K	54.08%-650.88K	58.95%-1.42M
Investing cash flow
Cash flow from continuing investing activities	0	-254.46%-5.92K	90.79%-1.67K	86.35%-18.11K	-9,931.22%-132.67K	-1.32K	0		87.85%-335.18K	73.95%-2.76M
Capital expenditure reported	----	----	----	----	----	----	----	----	85.28%-405.59K	73.48%-2.75M
Net PPE purchase and sale	--0	-254.46%-5.92K	75.96%-1.67K	---6.94K	--0	---1.32K	--0	----	1,552.67%70.41K	97.67%-4.85K
Net other investing changes	----	----	----	91.58%-11.17K	---132.67K	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	--0	-254.46%-5.92K	90.79%-1.67K	86.35%-18.11K	-9,931.22%-132.67K	---1.32K	--0	----	87.85%-335.18K	73.95%-2.76M
Financing cash flow
Cash flow from continuing financing activities	-33.41%6.21M	332.99%9.32M	-72.49%2.15M	712.50%7.83M	963.31K	0			-96.66%12.36K	-96.45%370.51K
Net issuance payments of debt	--0	--2M	--0	27,839.94%7.58M	---27.33K	--0	----	----	-28.53%12.36K	--17.29K
Net common stock issuance	-15.22%6.21M	--7.32M	--0	-76.78%230.02K	--990.64K	--0	----	----	----	----
Proceeds from stock option exercised by employees	--0	--0	13,468.18%2.15M	--15.87K	--0	----	----	----	----	56.50%353.22K
Cash from discontinued financing activities
Financing cash flow	-33.41%6.21M	332.99%9.32M	-72.49%2.15M	712.50%7.83M	--963.31K	--0	----	----	-96.66%12.36K	-96.45%370.51K
Net cash flow
Beginning cash position	49.79%4.05M	-60.80%2.7M	2,825.59%6.89M	-62.48%235.49K	-76.03%627.62K	-40.60%2.62M	0.23%4.41M	-29.89%4.4M	-40.36%6.27M	-33.03%10.52M
Current changes in cash	-302.32%-3.28M	148.91%1.62M	-153.42%-3.32M	1,771.58%6.21M	81.35%-371.42K	-24.85%-1.99M	-144.89%-1.59M	33.11%-651.27K	74.42%-973.71K	-5.32%-3.81M
Effect of exchange rate changes	122.88%63.5K	68.18%-277.54K	-295.89%-872.14K	2,249.98%445.22K	---20.71K	----	----	--0	30.64%-171.84K	8.21%-247.75K
End cash Position	-79.56%826.85K	49.79%4.05M	-60.80%2.7M	2,825.59%6.89M	-62.48%235.49K	-77.70%627.56K	-24.91%2.81M	-26.93%3.75M	-20.67%5.13M	-45.32%6.47M
Free cash flow	-23.24%-9.49M	-40.80%-7.7M	-240.34%-5.47M	-33.70%-1.61M	39.63%-1.2M	-24.85%-1.99M	-144.89%-1.59M	38.38%-651.27K	74.70%-1.06M	70.38%-4.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data